Hepatocellular carcinoma in the developing world

Seminars in Oncology

Volumn 28, Issue 2, 2001, Pages 179-187

  Ogunbiyi, J Olufemi ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; DEVELOPING COUNTRY; DIET; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; REVIEW;

EID: 0035045662     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(01)90090-9     Document Type: Article

References (76)

1. Rising incidence of hepatocellular carcinoma in the United States
2. Analysis of the causes of death on the medical wards of the University College Hospital, Ibadan over a 14-year period (1960-1973)
3. Increased incidence of prostate cancer in Nigerians
4. Hepatitis B virus, alpha fetoprotein synthesis, and hepatocellular carcinoma in Zaire
5. Epidemiology of primary liver cancer
6. Hepatoma in familial cholestatic cirrhosis in childhood: Its occurrence in twin brothers
7. Congenital hepatic fibrosis, liver cell carcinoma, and adult polycystic kidneys
8. Hepatocellular carcinoma with situs inversus
9. Gross anatomic features of hepatocellular carcinoma from three disparate geographical areas. Proposal for a new classification
10. Pathological characteristics of hepatocellular carcinoma
11. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients
12. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors
13. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: Relationship to disease stage, tumour size, and cirrhosis
14. Hepatocellular carcinoma in rural southern African blacks
15. The geographical approach in medical research
16. In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions
17. Is aflatoxin carcinogenic in man? The evidence in Swaziland
18. Dietary aflatoxin and liver cancer: A population based study in Kenya
19. Dietary aflatoxins and human liver cancer. IV. Incidence of primary liver cancer in two municipal populations of Thailand
20. Primary liver cancer rate and aflatoxin intake in a high cancer area
21. The aetiology of primary carcinoma of the liver in Africa: A critical appraisal of previous ideas with an outline of the mycotoxin hypothesis
22. The hepatotoxicity of some Ethiopian and East African plants, including some used in traditional medicines
23. Hepatocarcinogens in Nigerian foodstuffs
24. Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins
25. Prevalence of exposure to aflatoxin and hepatitis B and C viruses in Guinea, West Africa
26. Hepatocellular carcinoma: From gene to public health
27. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China
28. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China
29. HbsAg and aflatoxins in sera of rural (Igbo-Ora) and urban (Ibadan) populations in Nigeria
30. HbsAg, aflatoxins and primary hepatocellular carcinoma
31. Aflatoxin M1 in human breast milk from the Gambia, West Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC
32. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1
33. In vitro metabolism of aflatoxin B1 by normal and tumourous liver tissue from Thailand
34. Aflatoxin exposure and cytogenetic alterations in individuals from the Gambia, West Africa
35. P53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand
36. High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal
37. Database of p53 gene somatic mutations in human tumours and cell lines: Updated compilation and future prospects
38. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
39. Cirrhosis and hepatoma occurring at Boston City Hospital (1917-1968)
40. Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis. Strachan's 1929 thesis revisited
41. Preneoplastic significance of hepatic iron-free foci in genetic heamochromatosis
42. Hepatitis B virus: The major aetiology of hepatocellular carcinoma
43. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma
44. Persistence of hepatitis B virus DNA in the liver after loss of HbsAg in chronic hepatitis B
45. Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma
46. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas
47. Chromosome 17:7 translocation is associated with a hepatitis B virus DNA integration in human hepatocellular carcinoma DNA
48. Hepatitis B: Global importance and need for control
49. Prevention and control of hepatitis B
50. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma
51. Hepatocellular carcinoma in children
52. Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma
53. Hepatitis-B virus infection in southern African blacks with hepatocellular carcinoma
54. Hepatitis B viral markers in Nigerian patients with primary liver carcinoma
55. Sixty cases of primary hepatocellular carcinoma in one year: A preliminary appraisal
56. In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions
57. Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects, and prognosis in 100 consecutive patients of a university clinic
58. Hepatitis B and C virus and hepatocellular carcinoma
59. The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease
60. Hepatitis B and C viral infections in patients with hepatocellular carcinoma
61. Pathology of HCC in Japan; 232 consecutive cases autopsied in 10 years
62. Association of hepatitis C virus and hepatitis B virus in chronic liver disease
63. Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus anti-bodies in Nigerian patients with chronic liver disease
64. Long interval between HCV infection and development of hepatocellular carcinoma
65. Hepatitis D virus antigen in HbsAg positive chronic liver disease in Nigeria
66. Prevalence of hepatitis B, C, and D markers in subsaharan African migrants
67. Pathologic factors in cirrhosis with and without hepatocellular carcinoma: A multicenter Italian study
68. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis
69. Primary carcinoma of the liver in Ethiopia: A study of 38 cases proved at post-mortem examination
70. Spontaneous rupture of primary hepatocellular carcinoma in Zaria, Nigeria
71. Childhood mortality in Ibadan: An autopsy study
72. Latent hepatitis B virus infection in childhood hepatocellular carcinoma
73. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients
74. Hepatocellular carcinoma in infancy and childhood in Ibadan, Western Nigeria